More on GANX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+13.3% Growth)
- Ratings (8.8 Score)
- Holders

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Gain Therapeutics (NQ:GANX)
Delayed: 1.77 -0.03 (1.67%)
Prev. Close $1.80  
Open$1.83 
52 Wk High$ 
52 Wk Low$ 
Day High$1.83 
Day Low$1.77 
P/E N/A  
EPS$ 
Volume197,910 


Aug 31, 2026 06:54 AM H.C. Wainwright Reiterates Buy Rating on Gain Therapeutics (GANX)
Aug 25, 2026 07:00 AM Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
Aug 11, 2026 04:08 PM Form 10-Q Gain Therapeutics, Inc. For: Jun 30
Aug 11, 2026 04:06 PM Form 8-K Gain Therapeutics, Inc. For: Aug 11
Aug 11, 2026 07:20 AM Gain Therapeutics, Inc. (GANX) Tops Q2 EPS by 3c
Aug 11, 2026 07:00 AM Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update
Jul 17, 2026 08:33 AM Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: GOLDSTEIN DOV A MD
Jul 17, 2026 08:33 AM Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Nicaise Claude
Jul 17, 2026 08:32 AM Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Islam Khalid
Jul 17, 2026 08:32 AM Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Melincoff Gwen A
View All Articles

Entities mentioned with GANX

View All Entities